BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1567 related articles for article (PubMed ID: 22795814)

  • 21. Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?
    Asencio LA; Huang JJ; Alpert JS
    Am J Med; 2014 Jul; 127(7):579-85. PubMed ID: 24608021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 23. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
    Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
    Hansen ML; Sørensen R; Clausen MT; Fog-Petersen ML; Raunsø J; Gadsbøll N; Gislason GH; Folke F; Andersen SS; Schramm TK; Abildstrøm SZ; Poulsen HE; Køber L; Torp-Pedersen C
    Arch Intern Med; 2010 Sep; 170(16):1433-41. PubMed ID: 20837828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
    Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ
    Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.
    Enomoto Y; Iijima R; Tokue M; Ito N; Nagashima Y; Araki T; Yamazaki K; Utsunomiya M; Hori M; Itaya H; Shiba M; Hara H; Nakamura M; Sugi K
    Cardiovasc Interv Ther; 2014 Jul; 29(3):193-9. PubMed ID: 24366503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients.
    Hess CN; Broderick S; Piccini JP; Alexander KP; Newby LK; Shaw LK; Mahaffey KW; Alexander JH; Peterson ED; Granger CB; Lopes RD
    Am Heart J; 2012 Oct; 164(4):607-15. PubMed ID: 23067921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.
    Garcia DA; Lopes RD; Hylek EM
    Thromb Haemost; 2010 Dec; 104(6):1099-105. PubMed ID: 20886196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
    Subherwal S; Peterson ED; Chen AY; Roe MT; Washam JB; Gage BF; Bach RG; Bhatt DL; Wiviott SD; Lopes RD; Alexander KP; Wang TY
    Circulation; 2012 Mar; 125(11):1414-23. PubMed ID: 22319105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®.
    Ghanbari H; Nallamothu BK; Wang Y; Curtis JP
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.